MY106776A - Solid dosage forms of almokalant and processes for manufacture thereof. - Google Patents
Solid dosage forms of almokalant and processes for manufacture thereof.Info
- Publication number
- MY106776A MY106776A MYPI91002267A MYPI19912267A MY106776A MY 106776 A MY106776 A MY 106776A MY PI91002267 A MYPI91002267 A MY PI91002267A MY PI19912267 A MYPI19912267 A MY PI19912267A MY 106776 A MY106776 A MY 106776A
- Authority
- MY
- Malaysia
- Prior art keywords
- almokalant
- manufacture
- processes
- dosage forms
- solid dosage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/795—Polymers containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Chemical Treatment Of Metals (AREA)
Abstract
SOLID ORAL PHARMACEUTICAL DOSAGE FORMS CONTAINING A COMPLEX OF ALMOKALANT AS WELL AS PROCESSES FOR THEIR MANUFACTURE.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9003902A SE9003902D0 (en) | 1990-12-07 | 1990-12-07 | SOLID DOSAGE FORMS OF A DRUG |
Publications (1)
Publication Number | Publication Date |
---|---|
MY106776A true MY106776A (en) | 1995-07-31 |
Family
ID=20381121
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI91002267A MY106776A (en) | 1990-12-07 | 1991-12-06 | Solid dosage forms of almokalant and processes for manufacture thereof. |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP0560821A1 (en) |
JP (1) | JPH06503312A (en) |
CN (1) | CN1063039A (en) |
AP (1) | AP258A (en) |
AU (1) | AU8930791A (en) |
BG (1) | BG97851A (en) |
CA (1) | CA2097178A1 (en) |
CZ (1) | CZ103793A3 (en) |
FI (1) | FI932554A (en) |
HU (1) | HUT64217A (en) |
IE (1) | IE914137A1 (en) |
IL (1) | IL100150A0 (en) |
IS (1) | IS3788A7 (en) |
LT (1) | LTIP1717A (en) |
MA (1) | MA22355A1 (en) |
MX (1) | MX9102325A (en) |
MY (1) | MY106776A (en) |
NZ (1) | NZ240731A (en) |
PT (1) | PT99719A (en) |
SE (1) | SE9003902D0 (en) |
SK (1) | SK55693A3 (en) |
TN (1) | TNSN91117A1 (en) |
TW (1) | TW215057B (en) |
WO (1) | WO1992010172A1 (en) |
YU (1) | YU186891A (en) |
ZA (1) | ZA919264B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19602757A1 (en) * | 1996-01-26 | 1997-07-31 | Boehringer Mannheim Gmbh | Solid instant release dosage forms and processes for their manufacture |
GB9611328D0 (en) * | 1996-05-31 | 1996-08-07 | Zeneca Ltd | Pharmaceutical compositions |
US6024981A (en) * | 1997-04-16 | 2000-02-15 | Cima Labs Inc. | Rapidly dissolving robust dosage form |
JP4504467B2 (en) * | 1998-07-30 | 2010-07-14 | 佐藤製薬株式会社 | Orally disintegrating tablets |
JP7426685B2 (en) * | 2018-06-14 | 2024-02-02 | 株式会社東洋新薬 | tablet |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8705150D0 (en) * | 1987-12-23 | 1987-12-23 | Haessle Ab | NOVEL ANTIARRHYTHMIC AGENTS |
IL90245A (en) * | 1988-05-11 | 1994-04-12 | Glaxo Group Ltd | Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it |
SE8902236D0 (en) * | 1989-06-20 | 1989-06-20 | Haessle Ab | NOVEL POLYSTYRENESULPHONATE |
-
1990
- 1990-12-07 SE SE9003902A patent/SE9003902D0/en unknown
-
1991
- 1991-11-22 ZA ZA919264A patent/ZA919264B/en unknown
- 1991-11-25 IL IL100150A patent/IL100150A0/en unknown
- 1991-11-25 TW TW080109239A patent/TW215057B/zh active
- 1991-11-26 NZ NZ240731A patent/NZ240731A/en unknown
- 1991-11-27 YU YU186891A patent/YU186891A/en unknown
- 1991-11-28 IE IE413791A patent/IE914137A1/en unknown
- 1991-12-02 MX MX9102325A patent/MX9102325A/en unknown
- 1991-12-02 AP APAP/P/1991/000338A patent/AP258A/en active
- 1991-12-03 CZ CS931037A patent/CZ103793A3/en unknown
- 1991-12-03 MA MA22639A patent/MA22355A1/en unknown
- 1991-12-03 WO PCT/SE1991/000815 patent/WO1992010172A1/en not_active Application Discontinuation
- 1991-12-03 JP JP4500117A patent/JPH06503312A/en active Pending
- 1991-12-03 CA CA002097178A patent/CA2097178A1/en not_active Abandoned
- 1991-12-03 HU HU9301670A patent/HUT64217A/en unknown
- 1991-12-03 EP EP91920708A patent/EP0560821A1/en not_active Withdrawn
- 1991-12-03 SK SK55693A patent/SK55693A3/en unknown
- 1991-12-03 AU AU89307/91A patent/AU8930791A/en not_active Abandoned
- 1991-12-06 PT PT99719A patent/PT99719A/en not_active Application Discontinuation
- 1991-12-06 IS IS3788A patent/IS3788A7/en unknown
- 1991-12-06 MY MYPI91002267A patent/MY106776A/en unknown
- 1991-12-06 TN TNTNSN91117A patent/TNSN91117A1/en unknown
- 1991-12-07 CN CN91112789A patent/CN1063039A/en active Pending
-
1993
- 1993-06-04 BG BG97851A patent/BG97851A/en unknown
- 1993-06-04 FI FI932554A patent/FI932554A/en not_active Application Discontinuation
- 1993-12-30 LT LTIP1717A patent/LTIP1717A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ZA919264B (en) | 1992-08-26 |
IS3788A7 (en) | 1992-06-08 |
CN1063039A (en) | 1992-07-29 |
TW215057B (en) | 1993-10-21 |
FI932554A0 (en) | 1993-06-04 |
YU186891A (en) | 1994-04-05 |
CA2097178A1 (en) | 1992-06-08 |
PT99719A (en) | 1992-10-30 |
IE914137A1 (en) | 1992-06-17 |
IL100150A0 (en) | 1992-08-18 |
AP258A (en) | 1993-06-03 |
AU8930791A (en) | 1992-07-08 |
BG97851A (en) | 1994-04-29 |
TNSN91117A1 (en) | 1992-10-25 |
NZ240731A (en) | 1993-10-26 |
WO1992010172A1 (en) | 1992-06-25 |
MX9102325A (en) | 1992-06-01 |
JPH06503312A (en) | 1994-04-14 |
FI932554A (en) | 1993-06-08 |
EP0560821A1 (en) | 1993-09-22 |
LTIP1717A (en) | 1995-07-25 |
SE9003902D0 (en) | 1990-12-07 |
HU9301670D0 (en) | 1993-09-28 |
SK55693A3 (en) | 1993-10-06 |
AP9100338A0 (en) | 1992-01-31 |
HUT64217A (en) | 1993-12-28 |
MA22355A1 (en) | 1992-07-01 |
CZ103793A3 (en) | 1994-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL91768A0 (en) | Compounds being therapeutics for aids,their production and pharmaceutical compositions containing them | |
DE3360065D1 (en) | Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them | |
UA32512C2 (en) | Xanthine derivatives, a PROCESS for PREPARATION thereof and A pharmaceutical composition | |
ZA83362B (en) | Carboxyalkyl dipeptides,processes for their production and pharmaceutical compositions containing them | |
GR890100583A (en) | Method for the production of pharmaceutical compositions comprisig cyclosporins | |
AU590403B2 (en) | Pharmaceutical composition for the treatment of periodontal diseases | |
IL99163A0 (en) | Inhibitors for serine proteases,their preparation and pharmaceutical compositions containing them | |
NZ232084A (en) | Amino-phenyl-n-heterocyclic (ring b) compounds and pharmaceutical compositions | |
IL85972A0 (en) | Cephalosporin derivatives,their manufacture and pharmaceutical compositions containing them | |
ZA905861B (en) | Pharmaceutical composition for oral administration containing nac | |
IL89752A0 (en) | Bisphosphonates,their production and pharmaceutical compositions containing them | |
EP0448091A3 (en) | Pharmaceutical composition containing slightly water-soluble drug | |
IL87374A0 (en) | Cephalosporin derivatives,their manufacture and pharmaceutical compositions containing them | |
IL88927A0 (en) | Thienoazepines,their production and pharmaceutical compositions containing them | |
IL85722A0 (en) | Propiolophenone derivatives,their manufacture and pharmaceutical compositions containing them | |
MY106776A (en) | Solid dosage forms of almokalant and processes for manufacture thereof. | |
IL85970A0 (en) | Cephalosporin derivatives,their manufacture and pharmaceutical compositions containing them | |
IL84728A (en) | Bicyclic v-triazine-4-one derivatives,their manufacture and pharmaceutical compositions containing them | |
IL86640A (en) | Methoxymethyl penem compounds, their preparation and pharmaceutical compositions containing them | |
IL91246A0 (en) | Benzodiazepine compounds,their production and pharmaceutical compositions containing them | |
NO180450C (en) | Pharmaceutical formulations and process for the preparation of Form II dirithromycin | |
AU2798689A (en) | Oral dosage units for pharmaceuticals and their use and preparation | |
IL85624A0 (en) | Imidazodiazepine derivatives,their manufacture and pharmaceutical compositions containing them | |
JO1718B1 (en) | Solid dosage forms of almokalant and processes for manufacture thereof | |
IL90958A0 (en) | Cycloalkylthiazole derivatives,their manufacture and pharmaceutical compositions containing them |